Outcome of patients with HTLV-1-associated adult T-cell leukemia/lymphoma after SCT: A retrospective study by the EBMT LWP

Bone Marrow Transplantation

Volumn 49, Issue 10, 2014, Pages 1266-1268

  Bazarbachi, A ^a   Cwynarski, K ^b   Boumendil, A ^c   Finel, H ^c   Fields, P ^d   Raj, K ^d   Nagler, A ^e   Mohty, M ^c,f   Sureda, A ^g   Dreger, P ^h   Hermine, O ^i,j  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c HÔPITAL SAINT ANTOINE   (France)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e TEL AVIV UNIVERSITY   (Israel)

^f SORBONNE UNIVERSITÉ   (France)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ HÔPITAL NECKER ENFANTS MALADES   (France)

^j CNRS   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTIVIRUS AGENT; BORTEZOMIB; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; VINCRISTINE;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER REGISTRY; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DISEASE ASSOCIATION; FEMALE; GRAFT INFECTION; GRAFT SURVIVAL; GRAFT VERSUS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA RELAPSE; MALE; MIDDLE AGED; MYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; RETROSPECTIVE STUDY; SURVIVAL TIME; T CELL LYMPHOMA; DISEASE COURSE; HUMAN T CELL LEUKEMIA VIRUS 1; LEUKEMIA-LYMPHOMA, ADULT T-CELL; PROGNOSIS; TREATMENT OUTCOME;

ADULT; AGED; DISEASE PROGRESSION; FEMALE; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84926408109     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2014.143     Document Type: Article

References (22)

1. Yamamoto N, Hinuma Y. Antigens in an adult T-cell leukemia virus-producer cell line: reactivity with human serum antibodies. Int J Cancer 1982; 30: 289-293.
2. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77: 7415-7419.
3. Bazarbachi A, Ghez D, Lepelletier Y, Nasr R, de Thé H, El-Sabban ME et al. New therapeutic approaches for adult T-cell leukaemia. Lancet Oncol 2004; 5: 664-672.
4. Bazarbachi A, Suarez F, Fields P, Hermine O. How I treat adult T-cell leukemia/lymphoma. Blood 2011; 118: 1736-1745.
5. Tsukasaki K, Hermine O, Bazarbachi A, Ratner L, Ramos JC, Harrington Jr W et al. Definition, prognostic factors, treatment, and response criteria of adult T-cell leukemia-lymphoma: a proposal from an international consensus meeting. J Clin Oncol 2009; 27: 453-459.
6. Hermine O, Wattel E, Gessain A, Bazarbachi A. Adult T cell leukaemia: a review of established and new treatments. BioDrugs 1998; 10: 447-462.
7. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-1987). Br J Haematol 1991; 79: 428-437.
8. Tsukasaki K, Utsunomiya A, Fukuda H, Shibata T, Fukushima T, Takatsuka Y et al. VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemialymphoma: Japan Clinical Oncology Group Study JCOG9801. J Clin Oncol 2007; 25: 5458-5464.
9. Takasaki Y, Iwanaga M, Imaizumi Y, Tawara M, Joh T, Kohno T et al. Long-term study of indolent adult T-cell leukemia-lymphoma. Blood 2010; 115: 4337-4343.
10. Bazarbachi A, Plumelle Y, Carlos Ramos J, Tortevoye P, Otrock Z, Taylor G et al. Meta-analysis on the use of zidovudine and interferon-alfa in adult T-cell leukemia/lymphoma showing improved survival in the leukemic subtypes. J Clin Oncol 2010; 28: 4177-4183.
11. Hodson A, Crichton S, Montoto S, Mir N, Matutes E, Cwynarski K et al. Use of zidovudine and interferon alfa with chemotherapy improves survival in both acute and lymphoma subtypes of adult T-cell leukemia/lymphoma. J Clin Oncol 2011; 29 : 4696-4701.
12. Tsukasaki K, Maeda T, Arimura K, Taguchi J, Fukushima T, Miyazaki Y et al. Poor outcome of autologous stem cell transplantation for adult T cell leukemia/ lymphoma: a case report and review of the literature. Bone Marrow Transplant 1999; 23 : 87-89.
13. Phillips AA, Willim RD, Savage DG, Horwitz SM, Isola L, Zain JM et al. A multi-institutional experience of autologous stem cell transplantation in North American patients with human T-cell lymphotropic virus type-1 adult T-cell leukemia/lymphoma suggests ineffective salvage of relapsed patients. Leuk Lymphoma 2009; 50: 1039-1042.
14. Utsunomiya A, Miyazaki Y, Takatsuka Y, Hana da S, Uozumi K, Yashiki S et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 15-20.
15. Kami M, Hamaki T, Miyakoshi S, Murashige N, Kanda Y, Tanosaki R et al. Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma. Br J Haematol 2003; 120 : 304-309.
16. Fukushima T, Miyazaki Y, Honda S, Kawano F, Moriuchi Y, Masuda M et al. Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma. Leukemia 2005; 19: 829-834.
17. Okamura J, Utsunomiya A, Tanosaki R, Uike N, Sonoda S, Kannagi M et al. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma. Blood 2005; 105: 4143-4145.
18. Hishizawa M, Kanda J, Utsunomiya A, Taniguchi S, Eto T, Moriuchi Y et al. Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. Blood 2010; 116: 1369-1376.
19. Uike N, Tanosaki R, Utsunomiya A, Choi I, Okamura J. Can allo-SCT with RIC cure ATLL? Long-term survivors with excellent PS and with heterogenous HTLV-1 proviral load level. Retrovirology 2011; 8: A33-A33.
20. Marcais A, Suarez F, Sibon D, Bazarbachi A, Hermine O. Clinical trials of adult T-cell leukaemia/lymphoma treatment. Leuk Res Treatment 2012; 2012: 932175.
21. Itonaga H, Tsushima H, Taguchi J, Fukushima T, Taniguchi H, Sato S et al. Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience. Blood 2013; 121: 219-225.
22. Ishida T, Hishizawa M, Kato K, Tanosaki R, Fukuda T, Takatsuka Y et al. Impact of graft-versus-host disease on allogeneic hematopoietic cell transplantation for adult T cell leukemia-lymphoma focusing on preconditioning regimens: nationwide retrospective study. Biol Blood Marrow Transplant 2013; 19: 1731-1739.